Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial

O. Rascol; J. Bronzova; R.A. Hauser; A.E. Lang; C. Sampaio; A. Theeuwes; S.V. van de Witte

doi:10.1016/j.parkreldis.2011.12.006

Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2011.12.006 ◽

2012 ◽

Vol 18 (4) ◽

pp. 370-376 ◽

Cited By ~ 22

Author(s):

O. Rascol ◽

J. Bronzova ◽

R.A. Hauser ◽

A.E. Lang ◽

C. Sampaio ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Motor Fluctuations ◽

Double Blind ◽

Adjunct Therapy

Download Full-text

Faculty Opinions recommendation of Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726054684.793529088 ◽

2017 ◽

Author(s):

Wolfgang Oertel

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Motor Fluctuations ◽

Double Blind

Download Full-text

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(15)00336-1 ◽

2016 ◽

Vol 15 (2) ◽

pp. 154-165 ◽

Cited By ~ 103

Author(s):

Joaquim J Ferreira ◽

Andrew Lees ◽

José-Francisco Rocha ◽

Werner Poewe ◽

Olivier Rascol ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Motor Fluctuations ◽

Double Blind

Download Full-text

The ocean (opicapone effect on motor fluctuations and associated pain) study in Parkinson's disease: Design and rationale of a randomized double-blind placebo-controlled trial

Journal of the Neurological Sciences ◽

10.1016/j.jns.2021.119424 ◽

2021 ◽

Vol 429 ◽

pp. 119424

Author(s):

K. Ray Chaudhuri ◽

Per Odin ◽

Joaquim Ferreira ◽

Angelo Antonini ◽

Olivier Rascol ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Motor Fluctuations ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor Fluctuations: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

Neurology ◽

10.1212/wnl.48.1.81 ◽

1997 ◽

Vol 48 (1) ◽

pp. 81-87 ◽

Cited By ~ 141

Author(s):

M. C. Kurth ◽

C. H. Adler ◽

M. St. Hilaire ◽

C. Singer ◽

C. Waters ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Motor Function ◽

Controlled Trial ◽

Motor Fluctuations ◽

Double Blind

Download Full-text

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

The Lancet ◽

10.1016/s0140-6736(05)71083-7 ◽

2005 ◽

Vol 365 (9463) ◽

pp. 947-954 ◽

Cited By ~ 394

Author(s):

O Rascol ◽

DJ Brooks ◽

E Melamed ◽

W Oertel ◽

W Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Motor Fluctuations ◽

Double Blind ◽

Adjunct Therapy ◽

Once Daily ◽

Lasting Effect ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(18)30239-4 ◽

2018 ◽

Vol 17 (9) ◽

pp. 749-759 ◽

Cited By ~ 81

Author(s):

Regina Katzenschlager ◽

Werner Poewe ◽

Olivier Rascol ◽

Claudia Trenkwalder ◽

Günther Deuschl ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Motor Fluctuations ◽

Double Blind ◽

Subcutaneous Infusion

Download Full-text

Faculty Opinions recommendation of TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058963.510919 ◽

2007 ◽

Author(s):

Pascal Derkinderen

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Double Blind ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995409.793474520 ◽

2013 ◽

Author(s):

Cynthia Comella

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Extended Release ◽

Immediate Release ◽

Motor Fluctuations ◽

Double Blind Trial ◽

Phase 3 ◽

Double Blind ◽

Blind Trial

Download Full-text

Faculty Opinions recommendation of Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8286956.8718054 ◽

2011 ◽

Author(s):

Irene Litvan ◽

Rita Simoes

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Depressive Symptoms ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8638956.9139058 ◽

2011 ◽

Cited By ~ 1

Author(s):

John O'Brien ◽

John-Paul Taylor

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Dementia With Lewy Bodies ◽

Controlled Trial ◽

Lewy Bodies ◽

Parkinson’S Disease Dementia ◽

Double Blind ◽

Double Blind Placebo

Download Full-text